DEF 14A: HeartCore Enterprises Seeks Stockholder Approval for Reverse Stock Split and Director Elections

HeartCore Enterprises is holding a virtual annual meeting on September 27, 2024, to vote on the election of directors, a reverse stock split, and the ratification of its accounting firm.

Summary

• HeartCore Enterprises is convening its Annual Meeting of Stockholders virtually on September 27, 2024.
• Stockholders will vote on three key proposals: electing six directors, approving a reverse stock split, and ratifying the appointment of MaloneBailey, LLP as the independent auditor.
• The proposed reverse stock split aims to increase the company's stock price to comply with Nasdaq's minimum bid price requirement, with a ratio ranging from 1-for-2 to 1-for-10.
• The board recommends voting FOR all director nominees and FOR the reverse stock split and auditor ratification proposals.
• The record date for determining stockholders eligible to vote is August 2, 2024.
• As of the record date, there were 20,864,144 shares of common stock outstanding.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is taking steps to address a negative situation (Nasdaq non-compliance), there's no guarantee of success. The document is primarily informational.

Positives

• The company is taking proactive steps to address Nasdaq's minimum bid price requirement by proposing a reverse stock split.
• The company has a process in place for stockholders to communicate with the Board of Directors.
• The company has an Audit Committee consisting of three independent directors.
• The company has adopted a Code of Ethics and Business Conduct applicable to all directors, officers, and employees.
• The company has established a 2023 Equity Incentive Plan to attract and retain key personnel.

Negatives

• The company received a notice from Nasdaq regarding non-compliance with the $1.00 minimum bid price requirement.
• There is no assurance that the reverse stock split will increase the company's stock price or enable it to comply with the minimum bid price requirement.
• The company is a controlled company under Nasdaq rules, which exempts it from certain corporate governance requirements.
• The company does not have a compensation committee or a nominating and corporate governance committee.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could result in delisting.
• The reverse stock split may decrease the liquidity of the company's common stock and result in higher transaction costs.
• Other factors, such as financial results and market conditions, may adversely affect the market price of the company's common stock.
• There is no guarantee that the reverse stock split will attract capital investment in the company.

Future Outlook

The company is focused on regaining compliance with Nasdaq's minimum bid price requirement and believes that maintaining its Nasdaq listing is in the best interests of the company and its stockholders.

Management Comments

• Sumitaka Yamamoto, Chairman of the Board, Chief Executive Officer and President, urges stockholders to cast their vote as soon as possible.
• The Board of Directors believes that maintaining the Company's Nasdaq listing is in the best interests of the Company and its stockholders.

Industry Context

The reverse stock split is a common strategy employed by companies facing delisting from exchanges due to low stock prices. The company is attempting to maintain its listing status, which is often seen as a positive signal to investors.

Comparison to Industry Standards

• Reverse stock splits are a common tactic for companies facing delisting from exchanges like Nasdaq or NYSE.
• Companies like DryShips Inc. have used reverse stock splits to regain compliance, but the long-term success varies greatly depending on the company's underlying performance.
• The effectiveness of a reverse stock split is often compared to companies like Ocugen Inc., which saw a temporary price increase after a reverse split but ultimately needed further strategic changes to sustain growth.
• The company's decision to seek shareholder approval for a range of reverse split ratios (1-for-2 to 1-for-10) is similar to strategies used by companies like BioPharmX Corporation, which aimed to provide flexibility to the board in determining the optimal ratio based on market conditions.

Related Party Transactions

• The company has a due to related party balance of $1,476 from Sumitaka Yamamoto, the Chief Executive Officer (CEO) and major shareholder of the Company.
• The company has a loan receivable balance of $227,704 from Heartcore Technology Inc., a company controlled by the CEO of the Company.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, potentially affecting the value and liquidity of their shares.
• Employees may be affected by the company's ability to maintain its Nasdaq listing, which could impact its ability to attract and retain talent.
• The company's customers and suppliers may be affected by its financial stability and ability to continue operations.

Next Steps

• Stockholders will vote on the proposals at the Annual Meeting on September 27, 2024.
• The Board of Directors will determine whether to implement the reverse stock split and at what ratio, if approved by stockholders.
• The company will file an amendment to its Certificate of Incorporation with the Delaware Secretary of State if the reverse stock split is approved and implemented.

Key Dates

Keywords

reverse stock split, annual meeting, directors, proxy statement, Nasdaq, compliance, stockholders, HeartCore Enterprises, MaloneBailey, audit committee